Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

Share Price is delayed by 15 minutes
Get Live Data
186.10    1.00 (0.54%)
Bid:
186.20
Ask:
186.35
Spread: 0.15 (0.081%)
Market Cap: £8.43b
CNA Live PriceLast checked at - London Stock Exchange

Intraday Centrica Share Chart

Trading Update

10 Dec 2024 07:00

RNS Number : 4145P
Centrica PLC
10 December 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. Not for release, publication or distribution in whole or in part, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction

10 December 2024

Centrica plc 

 

Trading Update

 

Centrica plc (the "Company") will be holding a teach-in for institutional investors and analysts on its Centrica Energy and Meter Asset Provider (MAP) businesses at 2.30pm (GMT) this afternoon. A copy of the presentation will be available at www.centrica.com/investors prior to the event. Ahead of that, the Company provides the following update on its trading performance.

 

The Company has delivered good strategic progress in 2024, including announcing the extension of the lives of its four operational Advanced Gas-cooled Reactor ("AGR") nuclear power stations on 4th of December, and solid operating performance across the portfolio.

 

· The Company expects 2024 full year earnings per share to be broadly in line with analyst consensus1.

The usual uncertainties remain for the balance of the year, including weather, commodity prices and asset performance.

In aggregate, adjusted operating profit in Retail and Optimisation is expected to be in line with analyst consensus, including an improved financial result in Services & Solutions compared to 2023.

Infrastructure adjusted operating profit is also expected to be in line with analyst consensus based on year-to-date performance and the outlook for December, including hedging. This includes a second half loss for Centrica Energy Storage+.

2024 full year capital expenditure is expected to be around £600 million.

2024 closing net cash is expected to be in line with analyst consensus1.

· For 2025:

The Company expects all Retail Energy Supply and Optimisation businesses to be in the medium-term sustainable adjusted operating profit ranges.

British Gas Services & Solutions is expected to deliver a further improved financial result compared with 2024, as it continues its recovery towards its medium-term sustainable adjusted operating profit range by 2026.

2025 Infrastructure adjusted operating profit is currently expected to be in the range of £250 million - £400 million, subject to asset performance and commodity prices. This includes an expected adjusted operating loss in the range of £50 million - £100 million for Centrica Energy Storage+.

 

Centrica remains committed to its disciplined capital allocation framework, and is today announcing a £300 million extension to its existing share buyback programme. The extension, once completed, will mean the Company has repurchased £1.5 billion of its ordinary shares since November 2022, representing approximately 20% of the Company's issued share capital. The extension will begin as soon as practically possible and is expected to complete no later than the end of September 2025.

 

 

Enquiries:

Investors and Analysts: tel: +44 (0)1753 494900 email: ir@centrica.com

Media: tel: +44 (0)1784 843000 email: media@centrica.com

 

Notes:

1. As at 9th December 2024, the mean 2024 full year adjusted earnings per share from 11 sell side analyst forecasts published since Centrica's 2024 Interim Results announcement on 25th July 2024 is 18.5 pence, with a mean net cash forecast of £2.56 billion.

 

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654 Legal Entity Identifier number: E26EDV109X6EEPBKVH76 ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDDBDDDBGDGSC
Date   Source Headline
1st Jun 20263:45 pmRNSTotal Voting Rights
26th May 202612:30 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
18th May 20264:00 pmRNSDirector/PDMR Shareholding
15th May 20267:00 amRNSBritish Gas agrees PPM settlement
14th May 20264:42 pmRNSPublication of a Prospectus
12th May 20263:15 pmRNSDirector/PDMR Shareholding
12th May 202612:15 pmRNSDirector/PDMR Shareholding
12th May 20267:10 amRNSDirectorate change
7th May 202612:15 pmRNSResult of AGM
7th May 20267:00 amRNSAcquisition of the Severn CCGT for c.£370 million
7th May 20267:00 amRNSAGM Statement
1st May 20262:30 pmRNSTotal Voting Rights
27th Apr 20262:30 pmRNSDirector/PDMR Shareholding
13th Apr 20263:30 pmRNSDirector/PDMR Shareholding
1st Apr 202612:00 pmRNSTotal Voting Rights
31st Mar 202610:33 amRNSNotice of AGM
25th Mar 20262:00 pmRNSDirector/PDMR Shareholding
11th Mar 20266:15 pmRNSDirector/PDMR Shareholding
2nd Mar 202612:15 pmRNSTotal Voting Rights
25th Feb 20265:15 pmRNSDirector/PDMR Shareholding
19th Feb 20262:39 pmRNSAnnual Financial Report 2025
19th Feb 20267:10 amRNSDirectorate change
19th Feb 20267:00 amRNSPreliminary Results
11th Feb 20265:30 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSCentrica announces divestments
2nd Feb 20263:00 pmRNSTotal Voting Rights
26th Jan 20264:15 pmRNSDirector/PDMR Shareholding
13th Jan 20263:00 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:09 pmRNSTransaction in Own Shares - Replacement
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202612:30 pmRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20254:30 pmRNSCancellation of treasury shares
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20251:15 pmRNSDirector/PDMR Shareholding
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.